Shopping Cart
Remove All
Your shopping cart is currently empty
Enpp-1-IN-28 is an ENPP1 inhibitor with IC50 values of 0.188 µM at the molecular level and 0.732 µM at the cellular level. By preventing ENPP1 from hydrolyzing cGAMP, Enpp-1-IN-28 enhances the expression level of IFN-β in vivo, thereby triggering a stronger innate immune response. Enpp-1-IN-28 is applicable in metastatic breast cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Enpp-1-IN-28 is an ENPP1 inhibitor with IC50 values of 0.188 µM at the molecular level and 0.732 µM at the cellular level. By preventing ENPP1 from hydrolyzing cGAMP, Enpp-1-IN-28 enhances the expression level of IFN-β in vivo, thereby triggering a stronger innate immune response. Enpp-1-IN-28 is applicable in metastatic breast cancer research. |
| Targets&IC50 | ENPP1:0.188 μM |
| In vitro | Enpp-1-IN-28 (Compound 4e) exhibits cytotoxic activity against the 4T1 cell line with an IC50 of 2.99 μM, while showing no significant cytotoxic effect on normal cell lines (LO2 and 293T) at a concentration of 50 μM. |
| In vivo | Enpp-1-IN-28 (Compound 4e), administered intravenously as a single dose at 0.5 mg/kg, enhances the expression of IFN-β in the serum of BALB/c nude mice tumor models. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.